Wright Medical Group NV (NASDAQ:WMGI) SVP Andrew C. Morton sold 2,173 shares of the company’s stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $32.50, for a total transaction of $70,622.50. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
WMGI stock traded down $0.66 during trading on Friday, hitting $31.83. The company had a trading volume of 1,497,271 shares, compared to its average volume of 1,416,914. The company has a market capitalization of $4.08 billion, a P/E ratio of 808.50, a PEG ratio of 10.12 and a beta of 0.97. Wright Medical Group NV has a fifty-two week low of $22.55 and a fifty-two week high of $32.86. The company has a quick ratio of 0.70, a current ratio of 0.91 and a debt-to-equity ratio of 0.79.
Wright Medical Group (NASDAQ:WMGI) last posted its quarterly earnings data on Tuesday, May 7th. The medical device company reported $0.05 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.02. The business had revenue of $230.13 million during the quarter, compared to the consensus estimate of $226.10 million. Wright Medical Group had a negative net margin of 20.81% and a positive return on equity of 0.84%. The company’s quarterly revenue was up 15.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.01) earnings per share. Equities analysts anticipate that Wright Medical Group NV will post 0.21 EPS for the current year.
Several equities analysts have recently commented on the stock. BidaskClub upgraded shares of Wright Medical Group from a “hold” rating to a “buy” rating in a research report on Tuesday. Needham & Company LLC restated a “buy” rating and set a $38.00 price target on shares of Wright Medical Group in a research report on Wednesday, April 10th. Cantor Fitzgerald upped their price target on shares of Wright Medical Group from $35.00 to $39.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 27th. Credit Suisse Group upped their price target on shares of Wright Medical Group from $33.00 to $34.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 27th. Finally, Jefferies Financial Group upped their price target on shares of Wright Medical Group to $40.00 and gave the stock a “buy” rating in a research report on Wednesday, February 27th. Two investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. Wright Medical Group currently has an average rating of “Buy” and an average target price of $34.92.
ILLEGAL ACTIVITY WARNING: This news story was reported by Dakota Financial News and is the sole property of of Dakota Financial News. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of international trademark and copyright laws. The legal version of this news story can be read at https://dakotafinancialnews.com/2019/05/17/insider-selling-wright-medical-group-nv-wmgi-svp-sells-2173-shares-of-stock.html.
About Wright Medical Group
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.
Recommended Story: Trading based on a resistance level
Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.